Turn Therapeutics Inc. Common Stock (TTRX)

• Market cap: $140M
• 1 day: -1.19%
• 5 days: -19.35%
• 1 month: -28.57%
• 3 months: -28.57%
• 6 months: -28.57%
• Year to date: -28.57%
• 1 year: -28.57%
• 5 years: -28.57%
• 10 years: -28.57%
• Sector: Healthcare
• Industry: Biotechnology

About: Turn Therapeutics Inc is a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble APIs in oil-based carriers without the use of emulsifiers. This innovation reduces the quantity of required API inclusion by improving its bioavailability. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis.